Matches in Nanopublications for { <http://www.nextprot.org/nanopubs#NX_P51681-1_MUTAGEN_324_324.RAd6TzWoLx87nBD8erAh1M0x9BEVzB5WWeN7sr511Nd5s._1> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_P51681-1_MUTAGEN_324_324.RAd6TzWoLx87nBD8erAh1M0x9BEVzB5WWeN7sr511Nd5s._1 type RangedSequencePosition NX_P51681-1_MUTAGEN_324_324.RAd6TzWoLx87nBD8erAh1M0x9BEVzB5WWeN7sr511Nd5s.assertion.
- NX_P51681-1_MUTAGEN_324_324.RAd6TzWoLx87nBD8erAh1M0x9BEVzB5WWeN7sr511Nd5s._1 type SO_0001148 NX_P51681-1_MUTAGEN_324_324.RAd6TzWoLx87nBD8erAh1M0x9BEVzB5WWeN7sr511Nd5s.assertion.
- NX_P51681-1_MUTAGEN_324_324.RAd6TzWoLx87nBD8erAh1M0x9BEVzB5WWeN7sr511Nd5s._1 comment "Small reduction in palmitoylation. Cell surface expression reduced by 50%. Greatly reduced palmitoylation. Cell surface expression greatly reduced; when associated with A-321 or A-323. No palmitoylation. Cell surface expression greatly reduced. HIV entry reduced by 50%; when associated with A-321 and A-323." NX_P51681-1_MUTAGEN_324_324.RAd6TzWoLx87nBD8erAh1M0x9BEVzB5WWeN7sr511Nd5s.assertion.
- NX_P51681-1_MUTAGEN_324_324.RAd6TzWoLx87nBD8erAh1M0x9BEVzB5WWeN7sr511Nd5s._1 SIO_000053 NX_P51681-1_MUTAGEN_324_324.RAd6TzWoLx87nBD8erAh1M0x9BEVzB5WWeN7sr511Nd5s._2 NX_P51681-1_MUTAGEN_324_324.RAd6TzWoLx87nBD8erAh1M0x9BEVzB5WWeN7sr511Nd5s.assertion.
- NX_P51681-1_MUTAGEN_324_324.RAd6TzWoLx87nBD8erAh1M0x9BEVzB5WWeN7sr511Nd5s._1 SIO_000053 NX_P51681-1_MUTAGEN_324_324.RAd6TzWoLx87nBD8erAh1M0x9BEVzB5WWeN7sr511Nd5s._3 NX_P51681-1_MUTAGEN_324_324.RAd6TzWoLx87nBD8erAh1M0x9BEVzB5WWeN7sr511Nd5s.assertion.